AU7398300A - Chlamydia antigens and corresponding dna fragments and uses thereof - Google Patents

Chlamydia antigens and corresponding dna fragments and uses thereof

Info

Publication number
AU7398300A
AU7398300A AU73983/00A AU7398300A AU7398300A AU 7398300 A AU7398300 A AU 7398300A AU 73983/00 A AU73983/00 A AU 73983/00A AU 7398300 A AU7398300 A AU 7398300A AU 7398300 A AU7398300 A AU 7398300A
Authority
AU
Australia
Prior art keywords
dna fragments
corresponding dna
chlamydia antigens
chlamydia
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73983/00A
Inventor
Pamela Dunn
Andrew D. Murdin
Raymond P. Oomen
Joe Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of AU7398300A publication Critical patent/AU7398300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU73983/00A 1999-09-17 2000-09-15 Chlamydia antigens and corresponding dna fragments and uses thereof Abandoned AU7398300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15432599P 1999-09-17 1999-09-17
US60/154325 1999-09-17
PCT/CA2000/001086 WO2001021802A1 (en) 1999-09-17 2000-09-15 Chlamydia antigens and corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU7398300A true AU7398300A (en) 2001-04-24

Family

ID=22550898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73983/00A Abandoned AU7398300A (en) 1999-09-17 2000-09-15 Chlamydia antigens and corresponding dna fragments and uses thereof

Country Status (2)

Country Link
AU (1) AU7398300A (en)
WO (1) WO2001021802A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1032674T3 (en) * 1997-11-21 2007-04-10 Serono Genetics Inst Sa Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
EP1032676A2 (en) * 1997-11-28 2000-09-06 Genset $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION

Also Published As

Publication number Publication date
WO2001021802B1 (en) 2001-09-27
WO2001021802A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AU7398200A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU3760100A (en) Immunostimulatory nucleic acids and antigens
AU2001287430A1 (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
AU8173098A (en) Neuroprotective methods and reagents
AU2138501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2001248172A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248176A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248171A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU5245900A (en) Novel protein and dna thereof
AU2001248178A1 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
EP2088197B8 (en) Haemophilus influenzae antigens and corresponding DNA fragments
AU2001274566A1 (en) Novel protein and dna thereof
AU1891301A (en) Novel polypeptide and dna thereof
AU2138601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2001285155A1 (en) Polymorphic dna fragments and uses thereof
AU1375501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2002216863A1 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
AU5668500A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU7398400A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU1375601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU7398600A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU7398700A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU7398300A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU1375701A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase